Breast Cancer Risk Increased By The Use Of Combination Hormone-Replacement Therapy
According to new research from the Fred Hutchinson Cancer Research Institute in Seattle, women who use combination hormone-replacement therapy are at an increased risk of lobular breast cancer. Researchers came to their conclusion after analyzing data from over 4,000 postmenopausal women who had been diagnosed with breast cancer and over 4,000 women with no history of the disease. According to the study there was no risk of breast cancer of any type for women who used estrogen only. Source: Cancer, December 15, 2002.
According to new research from the Fred Hutchinson Cancer Research Institute in Seattle, women who use combination hormone-replacement therapy are at an increased risk of lobular breast cancer. Researchers came to their conclusion after analyzing data from over 4,000 postmenopausal women who had been diagnosed with breast cancer and over 4,000 women with no history of the disease. According to the study there was no risk of breast cancer of any type for women who used estrogen only. Source: Cancer, December 15, 2002.